These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 37023965)
1. Understanding the risks and benefits of policy action in NAFLD. Rowe IA J Hepatol; 2023 Jul; 79(1):22-24. PubMed ID: 37023965 [No Abstract] [Full Text] [Related]
2. A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe. Lazarus JV; Ekstedt M; Marchesini G; Mullen J; Novak K; Pericàs JM; Roel E; Romero-Gómez M; Ratziu V; Tacke F; Cortez-Pinto H; Anstee QM; J Hepatol; 2020 Jan; 72(1):14-24. PubMed ID: 31518646 [TBL] [Abstract][Full Text] [Related]
3. Risk for the development of non-alcoholic fatty liver disease: A prospective study. Wang J; Ma L; Chen S; Xu L; Miao M; Yu C; Li Y; Xu C J Gastroenterol Hepatol; 2018 Aug; 33(8):1518-1523. PubMed ID: 29381226 [TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases. Motamed N; Rabiee B; Poustchi H; Dehestani B; Hemasi GR; Khonsari MR; Maadi M; Saeedian FS; Zamani F Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):31-38. PubMed ID: 27597641 [TBL] [Abstract][Full Text] [Related]
5. Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis. Han AL BMC Endocr Disord; 2021 May; 21(1):91. PubMed ID: 33933056 [TBL] [Abstract][Full Text] [Related]
6. Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysis. Morrison AE; Zaccardi F; Khunti K; Davies MJ Liver Int; 2019 Mar; 39(3):557-567. PubMed ID: 30358050 [TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV. Verna EC Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):211-223. PubMed ID: 28404136 [TBL] [Abstract][Full Text] [Related]
8. Association between non-alcoholic fatty liver disease and the risk of biliary tract cancers: A South Korean nationwide cohort study. Park JH; Hong JY; Kwon M; Lee J; Han K; Han IW; Kang W; Park JK Eur J Cancer; 2021 Jun; 150():73-82. PubMed ID: 33892409 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. Athyros VG; Tziomalos K; Katsiki N; Doumas M; Karagiannis A; Mikhailidis DP World J Gastroenterol; 2015 Jun; 21(22):6820-34. PubMed ID: 26078558 [TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults. Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Avillach P; Egger P; Dhalwani NN; Kendrick S; Celis-Morales C; Waterworth DM; Alazawi W; Sattar N BMJ; 2019 Oct; 367():l5367. PubMed ID: 31594780 [TBL] [Abstract][Full Text] [Related]
13. Too much medicine: overdiagnosis and overtreatment of non-alcoholic fatty liver disease. Rowe IA Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):66-72. PubMed ID: 29254617 [TBL] [Abstract][Full Text] [Related]
14. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398 [TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease is associated with stroke severity and progression of brainstem infarctions. Li H; Hu B; Wei L; Zhou L; Zhang L; Lin Y; Qin B; Dai Y; Lu Z Eur J Neurol; 2018 Mar; 25(3):577-e34. PubMed ID: 29281159 [TBL] [Abstract][Full Text] [Related]
16. Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis. Huang JF; Tsai PC; Yeh ML; Huang CF; Huang CI; Hsieh MH; Dai CY; Yang JF; Chen SC; Yu ML; Chuang WL; Chang WY J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):89-96. PubMed ID: 30952479 [TBL] [Abstract][Full Text] [Related]
17. Vitamin D: a new player in non-alcoholic fatty liver disease? Eliades M; Spyrou E World J Gastroenterol; 2015 Feb; 21(6):1718-27. PubMed ID: 25684936 [TBL] [Abstract][Full Text] [Related]
18. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease. Panera N; Gnani D; Crudele A; Ceccarelli S; Nobili V; Alisi A World J Gastroenterol; 2014 Nov; 20(41):15079-86. PubMed ID: 25386056 [TBL] [Abstract][Full Text] [Related]
19. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease. Chinnadurai R; Chrysochou C; Kalra PA Nephron; 2019; 141(1):24-30. PubMed ID: 30384370 [TBL] [Abstract][Full Text] [Related]